Mobithron Advance for knee osteoarthritis: long-term effects
Official title: Long-Term Effects of Mobithron Advance on Knee Osteoarthritis
Run by Universiti Sains Malaysia · NCT07323745 · Data updated 2026-11-12
This study tests whether taking Mobithron Advance daily for a year can slow knee OA progression and improve symptoms in adults over 50.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | Universiti Sains Malaysia Academic / other |
| Locations | 1 site (Kota Bharu, Kelantan) |
| Status | Recruiting |
| Started | May 3, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | October 31, 2027 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07323745 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 50 with clinically and radiographically confirmed knee OA (Kellgren-Lawrence grades 1–3).
✕Probably not a fit
Patients with conflicting diagnoses, advanced OA (KL grade 4+), recent knee surgery plans, or exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-arm trial conducted at Hospital Universiti Sains Malaysia to assess the long-term safety and potential disease-modifying effects of Mobithron Advance in knee OA with Kellgren-Lawrence grades 1–3. Participants will receive oral Mobithron Advance daily for 12 months, with visits at 3, 6, and 12 months for assessments including pain (VAS), function (WOMAC), and MRI-based cartilage measurements, along with safety labs. Data will be analyzed descriptively and with appropriate longitudinal methods to observe changes over time. The study aims to determine if long-term treatment modifies OA progression and to characterize the safety profile in this population.
Why it matters
Potential benefit: If successful, Mobithron Advance could slow OA progression and reduce pain or functional impairment in knee OA.
How similar studies have gone: Previous studies with similar agents have shown mixed results; this trial explores long-term safety and potential progression modification in a defined KL 1–3 OA population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and female patients above 50 years old at the time of recruitment. * OA Diagnosis: Patients with one or both knee osteoarthritis according to clinical and radiological criteria of the American College of Rheumatology (ACR). * OA Grade: Kellgren Lawrence grade 1-3 Exclusion Criteria: * Secondary arthritis (e.g., rheumatoid arthritis, psoriatic arthritis). * History of joint surgery. * Patients who received steroid injection treatment within the last 3 months or hyaluronic acid injection treatment within the last 6 months. * Contraindications to Mobithron Advance (e.g., known allergies, severe liver or kidney disease). * Patients planning for knee surgery within the research period. * Patients on pharmacological treatment for osteoarthritis, other than rescue analgesic agent, e.g: glucosamine, chondroitin, oral steroid
Where it's running
-
Hospital Univerisiti Sains Malaysia (HUSM)
Kota Bharu, Kelantan, Malaysia Recruiting
Study contacts
- Study coordinator: Mohamad Anas Alfian Bin Sufri Dr., Medicine and Surgery
- Email: anas.alfian92@gmail.com
- Phone: +60192993482
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Platelet-rich plasma added to hyaluronic acid for knee osteoarthritis
This study tests whether a single injection of hyaluronic acid plus autologous platelet-rich plasma helps reduce knee OA symptoms more than hyaluronic acid alone in adults with moderate knee OA.
-
Hyaluronic Acid Plus PRP Injection for Knee Osteoarthritis
This study tests whether a single HA injection combined with a patient’s own PRP is better at easing knee OA pain than HA alone.
-
Long-acting local pain medicine after knee replacement
This study tests whether a new extended-release pain medicine (Zynrelef) given around the knee during total knee replacement can reduce pain after surgery better or as well as standard injections or nerve blocks.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Modular powered knee braces to help move better and reduce knee pain
A device with partial motor support is being tested in adults with knee OA to see if it can ease pain and reduce effort during daily activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.